Organon & Co. (OGN)

May 13, 2025, 10:00 AM EDT - 19 hours ago

Bronstein, Gewirtz & Grossman, LLC Encourages Organon & Co. (OGN) Stockholders to Inquire about Securities Investigation

May 12, 2025, 11:47 AM EDT - 1 day ago

Organon & Co: Cost Takeout Catalysts, Initiate Strong Buy

May 12, 2025, 10:00 AM EDT - 1 day ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organon & Co. (OGN) and Encourages Investors to Learn More About the Investigation

May 11, 2025, 10:00 AM EDT - 2 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Organon & Co. (OGN) And Encourages Stockholders to Connect

May 9, 2025, 10:00 AM EDT - 4 days ago

Organon & Co. (OGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 8, 2025, 11:08 AM EDT - 5 days ago

Organon: Management Slashes Dividend - This Feels Disastrous

May 8, 2025, 10:16 AM EDT - 5 days ago

EU drugs regulator confirms suicidal thoughts as side effect of anti hair-loss drug

GSK

May 8, 2025, 10:00 AM EDT - 5 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organon & Co. (OGN) and Encourages Stockholders to Learn More About the Investigation

May 7, 2025, 10:00 AM EDT - 6 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Organon & Co. (OGN) Investors to Inquire about Securities Investigation

May 6, 2025, 6:02 PM EDT - 7 days ago

Organon & Co. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - OGN

May 6, 2025, 1:00 PM EDT - 7 days ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Organon & Co. (OGN) And Encourages Investors to Reach Out

May 2, 2025, 10:00 AM EDT - 11 days ago

Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon

May 1, 2025, 2:55 PM EDT - 12 days ago

OGN Investors Have Opportunity to Join Organon & Co. Fraud Investigation with the Schall Law Firm

May 1, 2025, 11:31 AM EDT - 12 days ago

Organon & Co. (OGN) Q1 2025 Earnings Call Transcript

May 1, 2025, 7:00 AM EDT - 12 days ago

Organon Reports Results for the First Quarter Ended March 31, 2025

Apr 15, 2025, 5:00 PM EDT - 4 weeks ago

Organon Appoints Ramona A. Sequeira to the Company's Board of Directors

Apr 15, 2025, 7:31 AM EDT - 4 weeks ago

Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025

Apr 1, 2025, 7:30 AM EDT - 6 weeks ago

Organon Acquires TOFIDENCE™ (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA® (tocilizumab) Injection, for Intravenous Infusion in the U.S.

Mar 28, 2025, 6:00 AM EDT - 6 weeks ago

European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11

Mar 17, 2025, 10:58 PM EDT - 2 months ago

Why Organon Is A Top Pick For Income Investors

Mar 8, 2025, 9:00 AM EST - 2 months ago

New Analysis of Organon's VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older

Feb 19, 2025, 8:09 AM EST - 2 months ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

BMY PFE

Feb 17, 2025, 7:45 AM EST - 3 months ago

Organon: 7% Yield With A Bargain Basement Valuation

Feb 13, 2025, 12:47 PM EST - 3 months ago

Organon & Co. (OGN) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 7:30 AM EST - 3 months ago

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024

Jan 23, 2025, 7:30 AM EST - 3 months ago

Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025

Jan 17, 2025, 1:03 PM EST - 4 months ago

Organon: A Tricky 2025 Awaits, But I'm Happy With A >7% Dividend Yield

Jan 13, 2025, 9:38 PM EST - 4 months ago

Organon & Co. (OGN) JPMorgan Annual Healthcare Conference - (Transcript)

Dec 19, 2024, 7:30 AM EST - 5 months ago

Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 10, 2024, 1:40 PM EST - 5 months ago

Final Trades: Amazon, American Express and Organon

AMZN AXP

Nov 14, 2024, 12:42 PM EST - 6 months ago

Organon: 7% Yield, 4x P/E, Big Upside Potential

Nov 13, 2024, 8:30 AM EST - 6 months ago

Organon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade)

Oct 31, 2024, 12:28 PM EDT - 6 months ago

Organon & Co. (OGN) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 7:30 AM EDT - 6 months ago

Organon Reports Results for the Third Quarter Ended September 30, 2024

Oct 28, 2024, 9:25 AM EDT - 7 months ago

Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

Oct 22, 2024, 7:36 AM EDT - 7 months ago

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q4

ARQT TMDX

Oct 21, 2024, 2:12 PM EDT - 7 months ago

5 Stocks to Buy for a Harris Presidency

MSFT NEE RIVN STRL

Oct 9, 2024, 7:30 AM EDT - 7 months ago

Organon to Report Third Quarter 2024 Results and Host Conference Call on October 31, 2024

Oct 2, 2024, 1:35 PM EDT - 7 months ago

Final Trades: Organon, Howmet and the PSQ

HWM PSQ

Sep 18, 2024, 3:20 PM EDT - 8 months ago

Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B

ROIV